This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal

Arch Ophthalmol. 2000;118:848-850.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In 1980, Beckmann and Fuller¹ were the first to use the carbon dioxide (CO₂) laser in blepharoplastic surgery. Reported advantages of CO₂ laser blepharoplasty include decreased postoperative edema, less pain, and a shorter convalescence in comparison with conventional surgery.² We are aware of only 1 report on the use of a combined CO₂/Nd:YAG laser: in 1996, Katalinich³ reported that 50 patients treated for cutaneous neurofibromas had shorter surgery times, less hemorrhages, and sufficient removal with the Nd:YAG laser vs with the CO₂ laser alone. To the best of our knowledge, complications of this treatment have not yet been described.

Report of a Case

A 45-year-old man with Recklinghausen neurofibromatosis had undergone laser resurfacing because of multiple facial neurofibromas, especially in the periorbital region. He was treated in a plastic surgeon's office using, as far as we know, a combined CO₂/Nd:YAG laser (Combolaser; Madtec GmbH, Ulm, Germany) (power settings: CO₂ laser, 20-25 . . . [Full Text of this Article]

Comment
Helga Spelsberg, MD; Peter Hering, PhD; Thomas Reinhard, MD; Rainer Sundmacher, MD, FRCOphth
Düsseldorf, Germany

Corresponding author: Helga Spelsberg, MD, Eye Hospital, Heinrich-Heine-University, Moorenstrasse 5, 40225 Düsseldorf, Germany (e-mail: spelsber@uni-duesseldorf.de).